SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (11410)7/14/1998 3:50:00 AM
From: AlienTech  Respond to of 23519
 
>> It would behoove me to believe that Vivus is not clearly aware of this fact<<

We are both talking about the same company right?
:)

Just think.. If its all air comming out of wilson's fart, VVUS trading at less than book value is a certaintiy.



To: VLAD who wrote (11410)7/14/1998 7:54:00 AM
From: Edderd  Read Replies (1) | Respond to of 23519
 
Hey VLAD,
I'm not inclined to think that the PCP is the answer. They generally try not to stick anything in the patient's urethra. Note the minimal use of catheterization for urine cultures even in women. There are enough urologists in the USA to keep Vivus chugging right along and we are used to showing patients how to put things in the urethra. Instruction is the key to ease of use! PCP's like PILLS. Ease of use (for the Doc). All IMHO

Ed



To: VLAD who wrote (11410)7/14/1998 9:19:00 AM
From: John W. Andrews  Respond to of 23519
 
Vlad...

Certainly letting your salesforce go seems like a risky proposition and would indicate some sort of deal has taken place, however looking at possible produciton constraints with international sales booming, it may be that they see little repurcussions from that move....

It is very hard to speculate on this company..who knows...?/I think the only thing that we are sure about is that they are trying to make a profit this quarter and make the compnay more attractive....for whatever reason..

Pizzaman